{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:48:44Z","timestamp":1764604124368,"version":"3.46.0"},"reference-count":46,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["shmpublications.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Medicine"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatitis C (HCV) is a chronic, prevalent disease that disproportionately affects people who use drugs in the United States. One strategy to decrease HCV prevalence is the initiation of treatment during hospitalization. Factors affecting the success of this approach are not well\u2010characterized in the literature. Subspecialty providers in fields that treat substantial numbers of patients with HCV are well\u2010positioned to describe factors affecting treatment provision.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To understand barriers and facilitators of inpatient hepatitis C treatment from the perspectives of subspecialty physicians in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this qualitative research study, we interviewed 20 infectious diseases, hepatology, and addiction medicine physicians at 12 medical institutions across the United States. We analyzed interviews using a rapid matrix technique.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four major themes emerged: (1) hospitalization can be a gateway to care for patients who otherwise might not receive HCV treatment; (2) patients are vulnerable to being lost to follow\u2010up in the transition from inpatient to outpatient care; (3) the inpatient payment model is a barrier to widespread implementation of programs to treat HCV during hospitalization; and (4) treatment protocols and project \u201cchampions\u201d can support inpatient HCV treatment initiatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Physicians view hospitalization as an opportunity for patients to start HCV treatment. However, they have concerns about patients becoming lost to follow\u2010up after hospital discharge. Interviewees perceived that these concerns could be mitigated by implementing standardized protocols for HCV treatment with clear process ownership, as well as by dedicated funding for care navigators and systems champions. Lastly, physicians report that insurance coverage and reimbursement present major barriers to inpatient HCV treatment initiation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jhm.70097","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:39:49Z","timestamp":1749688789000},"page":"1323-1331","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Starting hepatitis C treatment during acute care hospitalizations: A qualitative study of barriers and facilitators"],"prefix":"10.1002","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6691-4628","authenticated-orcid":false,"given":"Erin","family":"Bredenberg","sequence":"first","affiliation":[{"name":"Division of Hospital Medicine University of Colorado Aurora Colorado USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Callister","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine University of Colorado Aurora Colorado USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Dafoe","sequence":"additional","affiliation":[{"name":"Adult and Child Center for Health Outcomes Research and Delivery Science Aurora Colorado USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke Dorsey","family":"Holliman","sequence":"additional","affiliation":[{"name":"Adult and Child Center for Health Outcomes Research and Delivery Science Aurora Colorado USA"},{"name":"Department of Family Medicine University of Colorado Anschutz Medical Campus Aurora Colorado USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Rowan","sequence":"additional","affiliation":[{"name":"Denver Health and Hospital Authority Denver Colorado USA"},{"name":"Division of Infectious Diseases University of Colorado Aurora Colorado USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0584-7783","authenticated-orcid":false,"given":"Susan L.","family":"Calcaterra","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine University of Colorado Aurora Colorado USA"},{"name":"Adult and Child Center for Health Outcomes Research and Delivery Science Aurora Colorado USA"},{"name":"Division of General Internal Medicine University of Colorado Aurora Colorado USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2020.306149"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6618a2"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003767"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.11.012"},{"journal-title":"Clin Infect Dis","article-title":"Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases\u2013Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection","author":"Bhattacharya D","key":"e_1_2_8_6_1"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00275-8"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00397-6"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13574"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108525"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14634"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.27326"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab526"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.11.003"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103356"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-023-08386-y"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad711"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/tbm\/ibz085"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01057-z"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-016-0242-z"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjq.2022.11.003"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000001553"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/104973230201200611"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad712"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.03.004"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.2196\/53049"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz694"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.06.002"},{"key":"e_1_2_8_31_1","unstructured":"Issue Brief: Upper Payment Limit Supplemental Payments. 2021. Accessed June 8 2025.https:\/\/www.macpac.gov\/wp-content\/uploads\/2021\/11\/Upper-Payment-Limit-Supplemental-Payments.pdf"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.3716"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1549-3741(04)30001-8"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/qhc.10.2.76"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)61194-4"},{"key":"e_1_2_8_36_1","unstructured":"America AAftSoLDatIDSo. Simplified HCV treatment for treatment\u2010naive adults without cirrhosis. 2025. Accessed 05\/02\/2025."},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-10867-7"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43058-022-00315-0"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.18161"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12717"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1801569"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-1-201301010-00012"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2019.00784"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1089\/pop.2021.0334"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.15782"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15245"},{"journal-title":"J Gen Intern Med","article-title":"Perspectives of in\u2010hospital intramuscular naltrexone and oral medications for alcohol use disorder: a study of addiction clinicians and hospitalized patients","author":"Calcaterra SL","key":"e_1_2_8_47_1"}],"container-title":["Journal of Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/shmpublications.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jhm.70097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:53:45Z","timestamp":1764590025000},"score":1,"resource":{"primary":{"URL":"https:\/\/shmpublications.onlinelibrary.wiley.com\/doi\/10.1002\/jhm.70097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1002\/jhm.70097"],"URL":"https:\/\/doi.org\/10.1002\/jhm.70097","archive":["Portico"],"relation":{},"ISSN":["1553-5592","1553-5606"],"issn-type":[{"type":"print","value":"1553-5592"},{"type":"electronic","value":"1553-5606"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"2025-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}